{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:08:12Z","timestamp":1770833292955,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T00:00:00Z","timestamp":1478649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T00:00:00Z","timestamp":1478649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To establish optimal biopsy scheme for selection of candidates for active surveillance (AS) among prostate cancer (PCa) patients, information on topographical distribution of tumor foci of higher grade missed by contemporary biopsy amongst potential candidates of AS would certainly be useful. Thus we analyzed topographic distribution of tumor foci by examining prostatectomy specimens in 444 patients who underwent radical prostatectomy for low risk PCa. Anterior and posterior prostate areas were demarcated by a horizontal line drawn at midpoint of prostatic urethra. Among 444 subjects, patients with upgrading showed relatively higher prevalence of index tumor foci in anterior prostate than those without upgrading, though not reaching statistical significance (p\u2009=\u20090.252). Meanwhile, among 135 (30.4%) patients with very low risk PCa, patients with upgrading showed significantly higher prevalence of index tumor foci in anterior prostate than those without upgrading (52.2% vs 33.8%; p\u2009=\u20090.031). In conclusions, tumor foci of higher grade missed by diagnostic biopsy were mostly located in anterior prostate among very low risk PCa patients. Such finding would be concrete evidence to support the notion that more efforts are needed to increase accuracy in detecting tumor foci in anterior prostate among potential candidates for AS.<\/jats:p>","DOI":"10.1038\/srep36781","type":"journal-article","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T10:09:06Z","timestamp":1478686146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Intraprostatic locations of tumor foci of higher grade missed by diagnostic prostate biopsy among potential candidates for active surveillance"],"prefix":"10.1038","volume":"6","author":[{"given":"Kwangmo","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Keun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gheeyoung","family":"Choe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Kyu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,9]]},"reference":[{"key":"BFsrep36781_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.6004\/jnccn.2016.0004","volume":"14","author":"JL Mohler","year":"2016","unstructured":"Mohler, J. L. et al. Prostate Cancer, Version 1 2016. J. Natl. Compr. Canc. Netw. 14, 19\u201330 (2016).","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"BFsrep36781_CR2","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.eururo.2005.11.007","volume":"49","author":"FK Chun","year":"2006","unstructured":"Chun, F. K. et al. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur. Urol. 49, 820\u2013826 (2006).","journal-title":"Eur. Urol."},{"key":"BFsrep36781_CR3","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.eururo.2012.01.050","volume":"61","author":"JI Epstein","year":"2012","unstructured":"Epstein, J. I., Feng, Z., Trock, B. J. & Pierorazio, P. M. Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades. Eur. Urol. 61, 1019\u20131024 (2012).","journal-title":"Eur. Urol."},{"key":"BFsrep36781_CR4","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1200\/JCO.2009.24.2180","volume":"28","author":"L Klotz","year":"2010","unstructured":"Klotz, L. et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J. Clin. Oncol. 28, 126\u2013131 (2010).","journal-title":"J. Clin. Oncol."},{"key":"BFsrep36781_CR5","first-page":"2185","volume":"29","author":"JJ Tosoian","year":"2011","unstructured":"Tosoian, J. J. et al. Active surveillance program for prostate cancer: an update of the Johns Hopkins experience. J. Urol. 29, 2185\u20132190 (2011).","journal-title":"J. Urol."},{"key":"BFsrep36781_CR6","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1002\/cncr.28303","volume":"119","author":"M Truong","year":"2013","unstructured":"Truong, M. et al. Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer. Cancer. 119, 3992\u20134002 (2013).","journal-title":"Cancer."},{"key":"BFsrep36781_CR7","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.juro.2014.02.2568","volume":"192","author":"SH Song","year":"2014","unstructured":"Song, S. H. et al. Predictors of unfavorable disease after radical prostatectomy in patients at low risk by D\u2019Amico criteria: role of multiparametric magnetic resonance imaging. J. Urol. 192, 402\u2013408 (2014).","journal-title":"J. Urol."},{"key":"BFsrep36781_CR8","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"AV D\u2019Amico","year":"1998","unstructured":"D\u2019Amico A. V. et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280, 969\u2013974 (1998).","journal-title":"JAMA"},{"key":"BFsrep36781_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jbi.2015.12.009","volume":"59","author":"O Eminaga","year":"2016","unstructured":"Eminaga, O. et al. Analysis of topographical distribution of prostate cancer and related pathological findings in prostatectomy specimens using cMDX document architecture. J. Biomed. Inform. 59, 240\u2013247 (2016).","journal-title":"J. Biomed. Inform."},{"key":"BFsrep36781_CR10","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.urology.2015.07.029","volume":"86","author":"O Eminaga","year":"2015","unstructured":"Eminaga, O. et al. Preoperative Serum Prostate-Specific Antigen Levels Vary According to the Topographical Distribution of Prostate Cancer in Prostatectomy Specimens. Urology 86, 798\u2013804 (2015).","journal-title":"Urology"},{"key":"BFsrep36781_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/pcan.2013.54","volume":"17","author":"J Mygatt","year":"2014","unstructured":"Mygatt, J. et al. Anterior tumors of the prostate: clinicopathological features and outcomes. Prostate Cancer Prostatic Dis. 17, 75\u201380 (2014).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"BFsrep36781_CR12","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/j.1464-410X.2009.08964.x","volume":"105","author":"JW Davis","year":"2010","unstructured":"Davis, J. W. et al. Radical prostatectomy findings in patients predicted to have low-volume\/low-grade prostate cancer diagnosed by extended-core biopsies: an analysis of volume and zonal distribution of tumour foci. BJU Int. 105, 1386\u20131391 (2010).","journal-title":"BJU Int."},{"key":"BFsrep36781_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.juro.2013.06.021","volume":"191","author":"D Sundi","year":"2014","unstructured":"Sundi, D. et al. Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men. J. Urol. 191, 60\u201367 (2014).","journal-title":"J. Urol."},{"key":"BFsrep36781_CR14","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1046\/j.1464-410X.2002.02796.x","volume":"89","author":"SR Bott","year":"2002","unstructured":"Bott, S. R., Young, M. P., Kellett, M. J. & Parkinson, M. C. Anterior prostate cancer: is it more difficult to diagnose? BJU Int. 89, 886\u2013889 (2002).","journal-title":"BJU Int."},{"key":"BFsrep36781_CR15","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1111\/j.1464-410X.2009.08938.x","volume":"105","author":"N Lawrentschuk","year":"2010","unstructured":"Lawrentschuk, N. et al. \u2018Prostatic evasive anterior tumours\u2019: the role of magnetic resonance imaging. BJU Int. 105, 1231\u20131236 (2010).","journal-title":"BJU Int."},{"key":"BFsrep36781_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.prnil.2015.09.006","volume":"3","author":"L Toner","year":"2015","unstructured":"Toner, L. et al. Magnetic resonance imaging for prostate cancer: Comparative studies including radical prostatectomy specimens and template transperineal biopsy. Prostate Int. 3, 107\u2013114 (2015).","journal-title":"Prostate Int."},{"key":"BFsrep36781_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.4111\/kju.2015.56.5.337","volume":"56","author":"NC Katelaris","year":"2015","unstructured":"Katelaris, N. C. et al. Current role of multiparametric magnetic resonance imaging in the management of prostate cancer. Korean J Urol. 56, 337\u2013345 (2015).","journal-title":"Korean J Urol."},{"key":"BFsrep36781_CR18","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.urology.2012.07.049","volume":"80","author":"P Motamedinia","year":"2012","unstructured":"Motamedinia, P. et al. Role of immediate confirmatory prostate biopsy to ensure accurate eligibility for active surveillance. Urology 80, 1070\u20131074 (2012).","journal-title":"Urology"},{"key":"BFsrep36781_CR19","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.juro.2012.04.104","volume":"188","author":"E Lecornet","year":"2012","unstructured":"Lecornet, E. et al. The accuracy of different biopsy strategies for the detection of clinically important prostate cancer: a computer simulation. J. Urol. 188, 974\u2013980 (2012).","journal-title":"J. Urol."},{"key":"BFsrep36781_CR20","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.juro.2012.04.107","volume":"188","author":"WE Barzell","year":"2012","unstructured":"Barzell, W. E. et al. Identifying candidates for active surveillance: an evaluation of the repeat biopsy strategy for men with favorable risk prostate cancer. J. Urol. 188, 762\u2013767 (2012).","journal-title":"J. Urol."},{"key":"BFsrep36781_CR21","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.urology.2010.08.048","volume":"77","author":"F Abdollah","year":"2011","unstructured":"Abdollah, F. et al. Trans-rectal versus trans-perineal saturation rebiopsy of the prostate: is there a difference in cancer detection rate? Urology 77, 921\u2013925 (2011).","journal-title":"Urology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep36781.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep36781","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep36781.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:23:31Z","timestamp":1672878211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep36781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,9]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep36781"],"URL":"https:\/\/doi.org\/10.1038\/srep36781","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,9]]},"assertion":[{"value":"13 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36781"}}